RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Guangdi Wang to Cytochrome P-450 CYP2D6

Back to Details
This is a "connection" page, showing publications Guangdi Wang has written about Cytochrome P-450 CYP2D6.
Guangdi Wang
Connection Strength
0.528
Cytochrome P-450 CYP2D6
  1. Zhong Q, Zhang C, Zhang Q, Miele L, Zheng S, Wang G. Boronic prodrug of 4-hydroxytamoxifen is more efficacious than tamoxifen with enhanced bioavailability independent of CYP2D6 status. BMC Cancer. 2015 Sep 09; 15:625.
    View in: PubMed
    Score: 0.528
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support